INFANTILE HEMANGIOMAS: ABSOLUTE INDICATIONS FOR ND: YAP Q-SW / KTP 1079/540 NM LASER TREATMENT

  • T. Trapeznikova South Ural State Medical University, Chelyabinsk, Russian Federation tayana_tr@mail.ru
  • A. Khlebnikova I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation alb9696@yandex.ru
Keywords: Infantile hemangioma, method for calculating the rapid proliferation of hemangioma, dangerous anatomical zones, Nd: YAP Q-Sw / KTP 1079/540 nm laser treatment

Abstract

Infantile hemangiomas, the most common neonatal tumors, are characterized by rapid proliferation which induces various complications. In such cases expectant tactics are not justified. The goal of the study was to determine the incidence of hemangiomas requiring active treatment modality and to assess absolute indications for treatment with the Nd: YAP Q-Sw / KTP method using two wavelengths of 1079/540 nm. Materials and methods. A prospective study of 122 children with infantile hemangiomas aged 1 to 24 months was conducted, including assessment of clinical picture of hemangiomas, distribution of hemangiomas according to their localization and size and ultrasound scanning. To calculate the tumor proliferation rate, the hemangioma size and its growth ratio relative to the patient’s body area in dynamics were determined. Absolute indications for Nd: YAP Q-Sw / KTP 1079/540 nm laser treatment of vascular tumors were: localization in dangerous anatomical zones (mucous membrane of the oral cavity, ear auricle, periorbital area, loin, perineum, hands and feet); the rapid growth of hemangioma regardless of location and size; the tumor location in the dermis (mixed hemangiomas) revealed by ultrasound investigation. Results. In 122 children 132 vascular tumors were detected. In 17 children (12.9 %) hemangiomas are located in anatomically dangerous areas. Of 132 hemangiomas ultrasound detected mixed tumors in 38 patients (28.8 %) and deep tumors in 10 children (7.57 %). Of 132 hemangiomas, laser treatment was absolutely indicated in 64.4 % (85) cases. In 10 (7.6 %) cases due to the deep localization of tumors other methods of treatment were indicated. In 37 (28 %) cases superficial hemangiomas laser treatment was used to stimulate involution. Conclusion. Rapid proliferation, localization of tumors in anatomically dangerous areas, mixed hemangiomas are absolute indications for Nd: YAP Q-Sw / KTP 1079/540 nm laser treatment to prevent complications and internal organs disorders.

References

1. Berezhnova S.G. [The Main Directions of Hemangiomas Treatment for Orbital and Paraorbital Localization in Children]. Rossiyskiyoftal'mologicheskiyzhurnal [Russian Ophthalmological Journal], 2013, vol. 6 (1), pp. 96–102. (in Russ.)
2. El'kin V.D., LysovA.Yu. [Practical Dermatooncology].Prakticheskayameditsina [Practical Medicine], 2014, pp. 480–483. (in Russ.)
3. Konoplitskiy D.V. [Classification Algorithm for the Treatment of External Hemangiomas in Children]. Molodiyvcheniy [Young Interviews], 2015, vol. 2–6 (17), pp. 618–622. (in Russ.)
4. Nurmeeva A.R., Mirolyubov A.L., Nurmeev I.N., Mirolyubov L.M., Nurmeev N.N. [Modern Technologies in the Diagnosis and Treatment of Hemangiomas]. Fundamental'nyeissledovaniya [Fundamental Research], 2013, no. 7, pp. 356–359. (in Russ.)
5. Chizhevskaya I.D. [Noninvasive Method of Treatment of Congenital Hemangiomas in the Maxillofacial Area in Children]. Pediatriya.VostochnayaEvropa [Pediatrics. Eastern Europe], 2015, vol. 3, pp. 166–160. (in Russ.)
6. Shakhno E.A. Fizicheskieosnovyprimeneniyalazerov v meditsine [Physical Principles of the Use of Lasers in Medicine]. St. Petersburg, NIU ITMO Publ., 2012. 129 p.
7. Sheptiy O.V., Kruglova L.S. [Infant Hemangioma. Classification, Clinical Picture and Methods of Correction]. Rossiyskiyzhurnalkozhnykh i venericheskikhbolezney [Russian Journal of Skin and Sexually Transmitted Diseases], 2016, vol. 3, pp. 183–178 (in Russ.).
8. Gey A., Ezzidine K., Diallo A., Prey S., Dreufus I., Maza A., Мazereeuw-Hautier J., Take A., Leaute-Labreze C. Stay in NICU and Infantile Haemangioma Development. EADV, 2015, vol. 29, pp. 573–566.
9. Keller R.G., Patel K.G. Evidence-Based Medicine in the Treatment of Infantile Hemangiomas. Facial PlastSurgClin North Am., 2015, vol. 23 (3), pp. 392–373.
10. Shen L., Zhou G., Zhao J. Pulsed Dye Laser Therapy for Infantile Hemangiomas: a Systemic Review and Meta-Analysis. QJM, 2015, vol. 108 (6), pp. 480–473.
11. Spence-Shishido A.A., Good W.V., Baselga E. Hemangiomas and the Eye. Clinics in Dermatology, 2015, vol. 33 (2), pp. 182–170.
12. Rosenberg T.L., Richter G.T. Lasers in the Treatment of Vascular Anomalies. Current Otorhinolaryngology Reports, 2014, vol. 2 (4), p. 265.
13. Trelles M. A Preliminary Report on the LINLINE Muititiple Wavelength Laser Platform. Institute Medic. Vilafortuny, Сambrils, Tarragona. 2012, pp. 438–450.

References on translit

1. Berezhnova S.G. [The Main Directions of Hemangiomas Treatment for Orbital and Paraorbital Localization in Children]. Rossiyskiyoftal'mologicheskiyzhurnal [Russian Ophthalmological Journal], 2013, vol. 6 (1), pp. 96–102. (in Russ.)
2. El'kin V.D., LysovA.Yu. [Practical Dermatooncology].Prakticheskayameditsina [Practical Medicine], 2014, pp. 480–483. (in Russ.)
3. Konoplitskiy D.V. [Classification Algorithm for the Treatment of External Hemangiomas in Children]. Molodiyvcheniy [Young Interviews], 2015, vol. 2–6 (17), pp. 618–622. (in Russ.)
4. Nurmeeva A.R., Mirolyubov A.L., Nurmeev I.N., Mirolyubov L.M., Nurmeev N.N. [Modern Technologies in the Diagnosis and Treatment of Hemangiomas]. Fundamental'nyeissledovaniya [Fundamental Research], 2013, no. 7, pp. 356–359. (in Russ.)
5. Chizhevskaya I.D. [Noninvasive Method of Treatment of Congenital Hemangiomas in the Maxillofacial Area in Children]. Pediatriya.VostochnayaEvropa [Pediatrics. Eastern Europe], 2015, vol. 3, pp. 166–160. (in Russ.)
6. Shakhno E.A. Fizicheskieosnovyprimeneniyalazerov v meditsine [Physical Principles of the Use of Lasers in Medicine]. St. Petersburg, NIU ITMO Publ., 2012. 129 p.
7. Sheptiy O.V., Kruglova L.S. [Infant Hemangioma. Classification, Clinical Picture and Methods of Correction]. Rossiyskiyzhurnalkozhnykh i venericheskikhbolezney [Russian Journal of Skin and Sexually Transmitted Diseases], 2016, vol. 3, pp. 183–178 (in Russ.).
8. Gey A., Ezzidine K., Diallo A., Prey S., Dreufus I., Maza A., Мazereeuw-Hautier J., Take A., Leaute-Labreze C. Stay in NICU and Infantile Haemangioma Development. EADV, 2015, vol. 29, pp. 573–566.
9. Keller R.G., Patel K.G. Evidence-Based Medicine in the Treatment of Infantile Hemangiomas. Facial PlastSurgClin North Am., 2015, vol. 23 (3), pp. 392–373.
10. Shen L., Zhou G., Zhao J. Pulsed Dye Laser Therapy for Infantile Hemangiomas: a Systemic Review and Meta-Analysis. QJM, 2015, vol. 108 (6), pp. 480–473.
11. Spence-Shishido A.A., Good W.V., Baselga E. Hemangiomas and the Eye. Clinics in Dermatology, 2015, vol. 33 (2), pp. 182–170.
12. Rosenberg T.L., Richter G.T. Lasers in the Treatment of Vascular Anomalies. Current Otorhinolaryngology Reports, 2014, vol. 2 (4), p. 265.
13. Trelles M. A Preliminary Report on the LINLINE Muititiple Wavelength Laser Platform. Institute Medic. Vilafortuny, Сambrils, Tarragona. 2012, pp. 438–450.
Published
2017-09-01
How to Cite
Trapeznikova, T., & Khlebnikova, A. (2017). INFANTILE HEMANGIOMAS: ABSOLUTE INDICATIONS FOR ND: YAP Q-SW / KTP 1079/540 NM LASER TREATMENT. Human. Sport. Medicine, 17(3), 52-60. https://doi.org/10.14529/hsm170306
Section
Clinical and Experimental Medicine